Conference Coverage
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
121-135 of 532
Preventing Serious Infections in Immunocompromised Patients
Living RheumPreventing Serious Infections in Immunocompromised Patients
Rethinking Lupus Nephritis: Targeting Immune Dysfunction
Living RheumRethinking Lupus Nephritis: Targeting Immune Dysfunction
Understanding Pediatric Eye Disorders: Key Insights from AAP 2025
Clinician's RoundtableUnderstanding Pediatric Eye Disorders: Key Insights from AAP 2025
Recognizing Neonatal FPIES: Key Clues for Early Diagnosis and Treatment
Clinician's RoundtableRecognizing Neonatal FPIES: Key Clues for Early Diagnosis and Treatment
Clinical Insights Into T-Cell Immunity After Pediatric COVID-19 mRNA Vaccination
Clinician's RoundtableClinical Insights Into T-Cell Immunity After Pediatric COVID-19 mRNA Vaccination
Pediatric RSV Hospitalizations Reveal Shifting Risk Profiles Post-Pandemic
Clinician's RoundtablePediatric RSV Hospitalizations Reveal Shifting Risk Profiles Post-Pandemic
- advertisement
Rethinking Chronic Pain: A Biopsychosocial Approach to Management
Living RheumRethinking Chronic Pain: A Biopsychosocial Approach to Management
Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
NeuroFrontiersDecoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
Timing Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
NeuroFrontiersTiming Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
Predicting Hydroxyurea Resistance in Polycythemia Vera with Machine Learning
Project Oncology®Predicting Hydroxyurea Resistance in Polycythemia Vera with Machine Learning
Clemastine Fumarate and Progressive MS: A Closer Look at Unexpected Risks and Mechanisms
NeuroFrontiersClemastine Fumarate and Progressive MS: A Closer Look at Unexpected Risks and Mechanisms
Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma
Project Oncology®Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma
- advertisement
Targeting CD19 in Autoimmune Neuropathy: Case Report Insights
Living RheumTargeting CD19 in Autoimmune Neuropathy: Case Report Insights
Reimagining Autoimmune Care with CAR-Based Cell Therapies
Living RheumReimagining Autoimmune Care with CAR-Based Cell Therapies
Examining Real-World Ibrutinib Outcomes in R/R MCL: Findings from a Danish Study
Project Oncology®Examining Real-World Ibrutinib Outcomes in R/R MCL: Findings from a Danish Study
